PortfoliosLab logoPortfoliosLab logo
RARE vs. DVLT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RARE vs. DVLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ultragenyx Pharmaceutical Inc. (RARE) and Datavault AI Inc (DVLT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RARE achieves a 8.30% return, which is significantly higher than DVLT's -46.08% return.


RARE

1D
-4.34%
1M
-25.58%
6M
3.49%
YTD
8.30%
1Y
-12.41%
3Y*
-16.59%
5Y*
-20.78%
10Y*
-8.91%
ALL TIME*
-4.76%

DVLT

1D
-2.27%
1M
-11.43%
6M
-49.33%
YTD
-46.08%
1Y
-31.00%
3Y*
-87.95%
5Y*
-90.79%
10Y*
ALL TIME*
-85.13%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$4.22M$4.86M$17.20M
$49.66M$56.10M$61.47M

RARE vs. DVLT - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
RARE
Ultragenyx Pharmaceutical Inc.
8.30%-45.33%-12.02%3.22%-44.90%-39.25%224.12%-1.77%-45.87%
DVLT
Datavault AI Inc
-46.08%-68.19%-88.31%-98.92%-92.24%-60.73%-70.98%-82.16%-31.60%

Correlation

The correlation between RARE and DVLT is 0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.05

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.09

Correlation (All Time)
Calculated using the full available price history since Jul 27, 2018

0.11

Fundamentals

Market Cap

RARE:

$2.45B

DVLT:

$96.26M

EPS

RARE:

-$6.09

DVLT:

-$0.44

PS Ratio

RARE:

3.72

DVLT:

2.38

Total Revenue (TTM)

RARE:

$669.43M

DVLT:

$39.38M

Gross Profit (TTM)

RARE:

$559.44M

DVLT:

$15.77M

EBITDA (TTM)

RARE:

-$522.35M

DVLT:

-$70.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RARE vs. DVLT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

RARE
RARE Risk / Return Rank: 4040
Overall Rank
RARE Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
RARE Sortino Ratio Rank: 4242
Sortino Ratio Rank
RARE Omega Ratio Rank: 4444
Omega Ratio Rank
RARE Calmar Ratio Rank: 3939
Calmar Ratio Rank
RARE Martin Ratio Rank: 3838
Martin Ratio Rank

DVLT
DVLT Risk / Return Rank: 4747
Overall Rank
DVLT Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
DVLT Sortino Ratio Rank: 6969
Sortino Ratio Rank
DVLT Omega Ratio Rank: 6262
Omega Ratio Rank
DVLT Calmar Ratio Rank: 3131
Calmar Ratio Rank
DVLT Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

RARE vs. DVLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ultragenyx Pharmaceutical Inc. (RARE) and Datavault AI Inc (DVLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RAREDVLTDifference
Sharpe ratioReturn per unit of total volatility

+0.04

Sortino ratioReturn per unit of downside risk

-1.09

Omega ratioGain probability vs. loss probability

1.05

1.14

-0.09

Calmar ratioReturn relative to maximum drawdown

-0.18

-0.38

+0.20

Martin ratioReturn relative to average drawdown

-0.34

-0.51

+0.18

RARE vs. DVLT - Sharpe Ratio Comparison

The current RARE Sharpe Ratio is -0.13, which is comparable to the DVLT Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of RARE and DVLT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RARE vs. DVLT - Drawdown Comparison

The maximum RARE drawdown since its inception was -89.57%, smaller than the maximum DVLT drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for RARE and DVLT.


Loading charts...

Drawdown Indicators


RAREDVLTDifference

Max Drawdown

Largest peak-to-trough decline

-89.57%

-100.00%

+10.43%

Max Drawdown (1Y)

Largest decline over 1 year

-49.37%

-90.18%

+40.81%

Max Drawdown (3Y)

Largest decline over 3 years

-68.83%

-99.85%

+31.02%

Max Drawdown (5Y)

Largest decline over 5 years

-81.93%

-100.00%

+18.07%

Max Drawdown (10Y)

Largest decline over 10 years

-89.57%

Current Drawdown

Current decline from peak

-85.96%

-100.00%

+14.04%

Average Drawdown

Average peak-to-trough decline

-55.11%

-90.73%

+35.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.28%

67.29%

-41.01%

Volatility

RARE vs. DVLT - Volatility Comparison

The current volatility for Ultragenyx Pharmaceutical Inc. (RARE) is 13.46%, while Datavault AI Inc (DVLT) has a volatility of 21.29%. This indicates that RARE experiences smaller price fluctuations and is considered to be less risky than DVLT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RAREDVLTDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.46%

21.29%

-7.83%

Volatility (6M)

Calculated over the trailing 6-month period

38.75%

79.00%

-40.25%

Volatility (1Y)

Calculated over the trailing 1-year period

67.17%

204.96%

-137.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.65%

192.40%

-137.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.21%

165.33%

-110.12%

Dividends

RARE vs. DVLT - Dividend Comparison

Neither RARE nor DVLT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

RARE vs. DVLT - Financials Comparison

This section allows you to compare key financial metrics between Ultragenyx Pharmaceutical Inc. and Datavault AI Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


RARE and DVLT have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DVLT has higher volatility (21.29%) compared to RARE (13.46%). In terms of maximum drawdown, RARE dropped -89.57% vs DVLT's -100.00%.

RARE currently has the higher Sharpe Ratio (-0.13 vs -0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RARE and DVLT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer